I meant to post last night that I picked up some Progenics yesterday. I have some lengthy notes which I will put up this morning but the rationale is:
- PDUFA in April,
- sNDA for product that has good data and been on market for 4 years so should have good chance of approval,
- Low trading volume – increased interest coming closer to catalyst should drive price,
- Good product with clear development strategy and decent commercial potential,
- Recent pull back to ascending trend line.
I added at an average price of $9.60.